Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Insiders Buy Shares at Agco, Ziopharm, and Mirati Therapeutics

By

Plus, a purchase at GulfSlope Energy.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.

Notable Purchases:
  • Mallika Srinivasan, a director at agricultural equipment manufacturer and distributor AGCO (NYSE:AGCO), bought 343,726 shares of company stock for $19,795,180.
  • Randal Kirk, a director at biotechnology company Ziopharm Oncology (NASDAQ:ZIOP), bought 2,857,143 shares of company stock for $10,000,000.
  • The healthcare-dedicated investment firm OrbiMed Advisors bought 125,000 shares of biopharmaceutical company Mirati Therapeutics (NASDAQ:MRTX) for $2,187,500. Mirati specializes in the development of therapeutics for the treatment of cancer.
  • James Askew, a director at shell company Gulfslope Energy (OTCBB:GSPE), bought 5,000,000 shares of company stock for $600,000. GulfSlope engages in the reseller market, specializing in promotional merchandise and apparel, employee recognition and incentive programs, and business gifts.
Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
DIR
AB
$19,795,180
2
DIR,BO
JB*
$10,000,000
3
BO
JB*
$2,187,500
4
DIR
B
$1,621,332
5
DIR,BO
JB*
$600,000
6
PR,CIO
B
$541,500
7
BO
B
$472,010
8
DIR,BO
B
$350,615
9
PR,CEO
B
$302,282
10
CEO,DIR
JB*
$210,000

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
DIR
AS
$110,374,536
2
VP
AS
$26,849,374
3
CEO,CB,BO
AS
$23,684,197
4
PR
S
$5,694,099
5
BO
S
$5,241,365
6
BO
S
$3,307,163
7
DIR
AS
$1,552,134
8
VP,CFO,TR
S
$1,503,057
9
VP,CFO
S
$1,496,209
10
BO
AS
$1,445,824

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
No positions in stocks mentioned.
PrintPRINT

Busy? Subscribe to our free newsletter!

Submit
 

WHAT'S POPULAR IN THE VILLE